Javier
Arbizu Lostao
Consultor Médico
Universitat Internacional de Catalunya
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Internacional de Catalunya (1)
2019
-
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: A cross-sectional analysis from the AB255 Study
Alzheimer's Research and Therapy, Vol. 11, Núm. 1